News Agency
Men's Weekly

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories

  • Written by PR Newswire
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
  • Kinnate has entered into an Asset Purchase Agreement (the "APA") with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets.
  • The transaction is in furtherance of Kinnate's previously announced pursuit of strategic alternatives.
  • This acquisition is intended to enable Pierre Fabre Laboratories to pursue its efforts...

Read more: Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre...

Why Shopify Web Development Is A Smart Choice For Growing Online Businesses

Building an online store that is reliable, scalable, and easy to manage requires more than choosing a popular platform. Professional Shopify web development provides businesses with a structured foundation that supports both current needs and future growth. Shopify’s flexibility allows stores... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion